ライフサイエンスコーパス: SANS

1 SANS (small-angle neutron scattering), SAXS (small-angle

2 SANS also statistically favored TC-5619 (P=0.030).

3 SANS data showed that isopropanol and pyridine both form

4 SANS experiment verifies that large quantities of small

5 SANS experiments are consistent with equivalent molecula

6 SANS measurements were performed on homogeneous solution

7 SANS profiles further revealed conformational diversity

8 SANS profiles were obtained from 10 degrees C to 55 degr

9 SANS results confirmed nanoparticles' functionalization

10 (r = 0.42; p = 0.021, r = 0.39; p = 0.033), SANS (r = 0.36; p = 0.049, r = 0.40; p = 0.027) and GAF

11 d 2 major alleles for SHMT1 1420 (ie, 4 of 4 SANS risk alleles).

12 Here we demonstrate a novel concept for a SANS instrument based on axisymmetric focusing mirrors.

13 For these 16 individuals, a SANS diagnosis or nondiagnosis from prior LDSF predicted

14 nique's inception about 40 years ago, as all SANS instruments, save a few, are still designed as pinh

15 ly greater direct effect than placebo on all SANS dimensions except anhedonia-asociality.

16 ril dimensions, as measured by TEM, AFM, and SANS indicate a fibril diameter of 6.4 nm, a height of 6

17 n between intracranial venous congestion and SANS.

18 or a potential link between WM-PVS fluid and SANS.

19 ement with the experimental hydrodynamic and SANS data.

20 ToF-SIMS), 2-D ToF-SIMS chemical imaging and SANS.

21 ded proteins, by cryo-TEM, LS, DOSY NMR, and SANS studies.

22 ive countermeasure for ocular remodeling and SANS during long-duration space missions.

23 We combine our SAXS and SANS experiments with molecular dynamics simulations and

24 gray matter volume for BPRS total score and SANS total score.

25 the virial coefficients measured by SLS and SANS was obtained without use of adjustable parameters.

26 ted by low neuroleptic dose and low baseline SANS total score.

27 milarity in CAMs suggests similarity between SANS-related changes in flight and ground datasets, prov

28 Both SANS data and the new computational model, the double su

29 ndent changes in a pentameric ion channel by SANS, an increasingly accessible method for macromolecul

30 equilibrium methods match those measured by SANS, which also allows reconstruction of the shape of t

31 ence of the bilayer spacings (as observed by SANS and SAXS) on the ratio between amount of water and

32 uch as framework void space were resolved by SANS, while contrast-matching experiments using D(2)O/H(

33 e nonionic surfactants for CO2 were shown by SANS to be capable of emulsifying up to 20 percent by we

34 ng structures are independently validated by SANS.

35 Combining SANS data with molecular modeling provided a first, to o

36 ith 48-mum pixels, we build the most compact SANS instrument in the world.

37 Neutron scattering models show that the CRP SANS data follow closely the data curve predicted for un

38 Moreover, NASA astronauts who developed SANS had greater pre- and postflight WM-PVS volumes than

39 iance may be at increased risk of developing SANS.

40 -echo modulated SANS (SEMSANS) and spin-echo SANS (SESANS) mode.

41 This affords a cost-effective SANS approach for obtaining novel structural information

42 f the alpha and beta domains in the ensemble SANS measurements, a likely result of enhanced domain mo

43 are in good agreement with the experimental SANS profiles when the persistence length of the assumed

44 uts (33.33%) met the diagnostic criteria for SANS.

45 ent the first and only reliable forecast for SANS, permitting precise in-flight treatment and prevent

46 edrest is a reasonable Earth-bound model for SANS.

47 sceptibility and interperson variability for SANS and permit prelaunch preparations for in-flight tre

48 Bilayer thickening was determined from SANS data.

49 Porosity values obtained from SANS are higher than those from two fluid-invasion metho

50 s a challenge to recover phase profiles from SANS measurements.

51 l-Purpose Small-Angle Neutron Scattering (GP-SANS) instrument at Oak Ridge National Laboratory.

52 However, SANS and LPNP methods exhibit a similar pore-size distri

53 e non-native protein conformations; however, SANS is ideally suited to the study of these associated

54 By combining HP-SANS and HP-ultraviolet/visible absorption spectroscopy,

55 a minimum of 20% reduction from baseline in SANS-18 score.

56 h placebo (group difference, -0.33 change in SANS score per week; 95% CI, -0.62 to -0.05) when genoty

57 nefit with active treatment (-0.59 change in SANS score per week; 95% CI, -0.99 to -0.18).

58 t), mean (95% confidence interval) change in SANS-18 scores was -12.9 (-15.0, -10.8; P<0.0001).

59 ated mechanism behind the ocular findings in SANS.

60 e 50-mg dose produced a mean 21% increase in SANS score.

61 eline) were found between placebo and LDX in SANS-18 or PANSS subscale scores.

62 phase information that is typically lost in SANS measurements.

63 Reductions in SANS scores were also significantly greater with clozapi

64 Contrast variation techniques in SANS enable measurement of the composition of the protei

65 ntyl glycol was experimentally undetected in SANS.

66 Using contrast variation in SANS measurements, we found that the B808-866 complex is

67 nce comparable to that of conventional large SANS facilities.

68 had significantly higher MMSE scores, lower SANS scores, more years of education, and were younger t

69 he applicability and outlook of microfluidic-SANS for high-throughput and flow processing studies, wi

70 s equipped to operate in spin-echo modulated SANS (SEMSANS) and spin-echo SANS (SESANS) mode.

71 class VII myosin and adaptor proteins: Myo7a/SANS/Harmonin in stereocilia and Myo7b/ANKS4B/Harmonin i

72 le scattering of x-rays (SAXS) and neutrons (SANS) are particularly useful and complementary techniqu

73 The joint NMR/SANS data analyses of three disease variants (L110V, R15

74 The primary outcome was SANS or non-SANS diagnosis, determined by OCT-based ODE data for eac

75 improving resolution, paves the way to novel SANS instruments, thus affecting a broad community of sc

76 The analyses of SANS patterns as a function of different solution condit

77 Using ensemble-optimized analysis of SANS data, we extracted the molecular size distribution

78 The archaeological application of SANS is demonstrated through a case study of 50 late Rom

79 The combination of SANS and modeling clearly enabled us to infer the soluti

80 A combination of SANS, ESI-MS and fluorescence quenching measurements ind

81 However, the basic design of SANS facilities has not changed since the technique's in

82 The etiology of SANS is unknown; it is hypothesized that venous outflow

83 The clinical findings of SANS have been correlated with structural changes on int

84 body weight, and clinical manifestations of SANS.

85 down tilt bedrest as an Earth-bound model of SANS (ground data).

86 Ab initio modeling of SANS shows that the oligomers formed from the BLG-retino

87 A) has documented the variable occurrence of SANS in astronauts returning from long-duration space fl

88 The pathophysiology of SANS remains elusive, and no predictors of SANS have bee

89 f SANS remains elusive, and no predictors of SANS have been discovered; reliable prediction may offer

90 o the authors' knowledge, no other report of SANS documented as large of a change in peripapillary TR

91 ng with light that, within the resolution of SANS, appears to be completely reversible.

92 al NCs, enabled by the unique sensitivity of SANS to organic molecules.

93 Further study of SANS is ongoing for consideration of future manned missi

94 The use of SANS is systematically investigated through over 400 mea

95 s greater than that for total pores based on SANS results for all four tested samples.

96 l Angle X-ray or Neutron Scattering (SAXS or SANS), it is possible to follow in situ the formation of

97 Further, our SANS measurements indicate that the chlorosome is a lipi

98 of chlorosome particles are suggested in our SANS measurements.

99 d DNA, which allows accurate modeling of our SANS data.

100 We then performed SANS to extract the ligand shell thickness and compositi

101 AI models can predict SANS based on pre-flight OCT imaging with moderate-to-hi

102 deep learning models were trained to predict SANS onset by using two OCT datasets: pre- and inflight

103 evaluated based on their ability to predict SANS using only pre-flight or pre-bedrest imaging in bot

104 is or nondiagnosis from prior LDSF predicted SANS diagnosis during subsequent LDSF (sensitivity, 85.7

105 Using the low resolution SANS shapes of the protein and lipid core as scaffolding

106 Although several sophisticated SAXS/SANS programs have been developed recently, the impact o

107 on the hydration shell by a systematic SAXS/SANS study using three mutants of a single protein, gree

108 Absolute-scale SANS employing a novel contrast-match-point analysis rev

109 ipoplexes by small-angle neutron scattering (SANS) and by cryogenic transmission electron microscopy

110 g in situ HP-small-angle neutron scattering (SANS) and HP-ultraviolet/visible absorption spectroscopy

111 Small-angle neutron scattering (SANS) and hydrogen-deuterium exchange mass spectrometry

112 ring (SAXS), small angle neutron scattering (SANS) and low-pressure N2 adsorption techniques.

113 Small angle neutron scattering (SANS) and molecular dynamics (MD) simulations were used

114 Small-angle neutron scattering (SANS) and neutron spin echo (NSE) spectroscopy were used

115 we calculate small-angle neutron scattering (SANS) and NSE scattering properties.

116 Small-angle neutron scattering (SANS) and transmission electron microscopy (TEM) confirm

117 ation, while small-angle neutron scattering (SANS) can be used to examine micelle fusion/fission and

118 Small-angle neutron scattering (SANS) can directly characterize the ligand shell structu

119 g (SAXS) and Small-Angle Neutron Scattering (SANS) characterizations.

120 ons from the small-angle neutron scattering (SANS) data indicate that both the polyradical with 24 tr

121 s applied to small angle neutron scattering (SANS) data is used to determine the in vitro conformatio

122 attering and small-angle neutron scattering (SANS) data.

123 analysis of small-angle neutron scattering (SANS) data.

124 with recent small angle neutron scattering (SANS) experiments (from 21.4 A at pH 10 to 21.5 A at pH

125 Small-angle neutron scattering (SANS) experiments confirmed its asymmetry and yielded an

126 btained from small-angle neutron scattering (SANS) experiments of poly(d-glucose carbonate) block cop

127 y performing small-angle neutron scattering (SANS) experiments on isolated triskelia, allowing us to

128 confirmed by small-angle neutron scattering (SANS) experiments on these fluids.

129 onstrated at small-angle neutron scattering (SANS) facilities.

130 rature using small-angle neutron scattering (SANS) in combination with molecular dynamics (MD) simula

131 Standard small-angle neutron scattering (SANS) instruments are sensitive in a range of ~ 10-200 n

132 Small-angle neutron scattering (SANS) is the most significant neutron technique in terms

133 Small-angle neutron scattering (SANS) is used to confirm the dramatic reduction in micel

134 in operando small-angle neutron scattering (SANS) is used to directly detect ion movements into the

135 Small-angle neutron scattering (SANS) is used to probe the solution structure of two pro

136 ion with the small angle neutron scattering (SANS) measurement.

137 Small-angle neutron scattering (SANS) measurements show that the phase transition from v

138 Small-angle neutron scattering (SANS) measurements were performed on a solution of singl

139 Small angle neutron scattering (SANS) measurements were performed on solutions of cAMP r

140 Small-angle neutron scattering (SANS) measurements were used to provide detailed informa

141 tch point in small-angle neutron scattering (SANS) measurements.

142 iation using small-angle neutron scattering (SANS) methods.

143 analysis of small-angle neutron scattering (SANS) on graphene-based biosensor functionalized with GO

144 Small angle neutron scattering (SANS) provides a method to obtain important low-resoluti

145 Small angle neutron scattering (SANS) provides the radii of gyration of 1.2-1.8 nm.

146 Small-angle neutron scattering (SANS) revealed a concentration-independent rod-shaped as

147 We performed small-angle neutron scattering (SANS) studies to obtain structural information about the

148 , we utilize small-angle neutron scattering (SANS) to directly quantify the key structure parameters

149 ology, using small-angle neutron scattering (SANS) to investigate pottery forming techniques through

150 rization and small-angle neutron scattering (SANS) to investigate the changes in membrane structure a

151 ere, we used small-angle neutron scattering (SANS) to probe ambient solution-phase properties of the

152 used in situ small-angle neutron scattering (SANS) to probe deuterated green fluorescent protein (d-G

153 Here, we use small-angle neutron scattering (SANS) to reveal the scattering form factor of dsDNA pack

154 tion NMR and small-angle neutron scattering (SANS) to structurally characterize full-length NHERF1 an

155 Small angle neutron scattering (SANS) was able to disclose the domain of entrapped drug

156 Here, small-angle neutron scattering (SANS) was employed to probe porosity changes in a highly

157 Finally, small-angle neutron scattering (SANS) was used to quantify the aggregate dimensions in s

158 MAS) NMR and small-angle neutron scattering (SANS) were consistent with a structural model that invol

159 We applied small angle neutron scattering (SANS) with contrast variation and selective isotopic deu

160 s, including small angle neutron scattering (SANS) with contrast variation, hydrogen-deuterium exchan

161 etermined by small-angle neutron scattering (SANS), a nondestructive technique that did not decrease

162 y (cryo-EM), small-angle neutron scattering (SANS), and molecular dynamics (MD) simulations.

163 luorescence, small angle neutron scattering (SANS), and rheological methods.

164 pectroscopy, small-angle neutron scattering (SANS), atomic force microscopy (AFM) based force spectro

165 ry (NR), and small-angle neutron scattering (SANS), have already been heavily adopted by the scientif

166 tegration of small-angle neutron scattering (SANS), low-pressure N2 physisorption (LPNP), and mercury

167 ch combining small-angle neutron scattering (SANS), low-resolution electron microscopy and biophysica

168 ring (SAXS), Small Angle Neutron Scattering (SANS), spectroscopic techniques like NMR and EPR, and ex

169 ation and by small-angle neutron scattering (SANS).

170 rimetry, and small-angle neutron scattering (SANS).

171 estigated by small-angle neutron scattering (SANS).

172 ng (SLS) and small-angle neutron scattering (SANS).

173 strated with small-angle neutron scattering (SANS).

174 luidics with small angle neutron scattering (SANS).

175 ymer through small-angle neutron scattering (SANS).

176 of DNA using small-angle neutron scattering (SANS).

177 technique of small-angle neutron scattering (SANS).

178 ast-matched, small-angle neutron-scattering (SANS) experiments to examine SecA in small unilamellar v

179 Small-angle neutron-scattering (SANS) measurements are used to provide detailed informat

180 ), small-angle neutron and X-ray scattering (SANS and SAXS) as well as cryogenic transmission electro

181 Using small-angle neutron/X-ray scattering (SANS/SAXS), we show that the addition of several natural

182 sment of Negative Symptoms of Schizophrenia (SANS) and the Brief Psychiatric Rating Scale (BPRS).

183 Significantly, SANS is non-destructive, suitable for both coarse and fi

184 Based on in situ SANS results, D s slightly decreases with increasing arg

185 simulation-derived and experimental-solution SANS results are in excellent agreement.

186 In this cohort study, SANS cases from previous LDSF were highly likely to be d

187 ale for the Assessment of Negative Symptoms (SANS) (range, 0-125), Montgomery-Asberg Depression Ratin

188 ale for the Assessment of Negative Symptoms (SANS) and Brief Psychiatric Rating Scale (BPRS) assessed

189 ale for the Assessment of Negative Symptoms (SANS) and several secondary measures were compared.

190 he Scale of Assessment of Negative Symptoms (SANS) and Social and Occupational Functioning Assessment

191 ale for the Assessment of Negative Symptoms (SANS) and the Brief Psychiatric Rating Scale (BPRS) were

192 ale for the assessment of negative symptoms (SANS) and the modified Hamilton rating scale for depress

193 ale for the Assessment of Negative Symptoms (SANS) total score (HR=1.02, 95% CI: 1.00-1.03, p=0.022),

194 ale for the Assessment of Negative Symptoms (SANS) total scores and change in the average cognitive d

195 ale for the Assessment of Negative Symptoms (SANS) total scores.

196 ale for the Assessment of Negative Symptoms (SANS), among other measures.

197 ale for the Assessment of Negative Symptoms (SANS), the Geriatric Depression Scale and by age.

198 ule for the Assessment of Negative Symptoms (SANS).

199 ; Scale for Assessment of Negative Symptoms (SANS); Clinical Global Impression-Global Improvement (CG

200 ale for the Assessment of Negative Symptoms (SANS); the 50-mg dose produced a mean 21% increase in SA

201 ale for the Assessment of Negative Symptoms (SANS-18) and Positive and Negative Syndrome Scale (PANSS

202 paceflight-associated neuro-ocular syndrome (SANS) affects astronauts on missions to the Internationa

203 paceflight-associated neuro-ocular syndrome (SANS) could severely impact astronaut performance during

204 ace flight-associated neuro-ocular syndrome (SANS) has been adopted as an appropriate descriptive ter

205 paceflight-associated neuro-ocular syndrome (SANS) may influence its management.

206 paceflight-associated neuro-ocular syndrome (SANS) occurs in 40% to 60% of National Aeronautics and S

207 and space-associated neuro-ocular syndrome (SANS) over many months.

208 paceflight associated neuro-ocular syndrome (SANS) was not associated with PVS number or morphology.

209 paceflight-associated neuro-ocular syndrome (SANS).

210 pneumolysin activates the complement system.SANS data at a variety of neutron contrasts were obtaine

211 n a detailed comparison, we demonstrate that SANS, SAXS, and GISAXS reveal distinct but complementary

212 The results show that SANS can be used to differentiate wheel-throwing, coil-b

213 nd anterior movement of the ONH support that SANS is caused by an altered pressure difference between

214 The SANS data also demonstrated that the RNA and nucleocapsi

215 The SANS data from the CRP* and cAMP-ligated CRP* are coinci

216 The SANS data indicate that nucleotide turnover can function

217 The SANS data were collected in a number of (1)H:(2)H solven

218 The SANS has blurred vision and ocular changes as typical fe

219 The SANS studies show that the cross-sections of fibers in t

220 The SANS-based in vitro structures indicate that lysozyme tr

221 The SANS-based in vitro structures indicate that under visib

222 There were negative correlations between the SANS total score and rCBF in both the left dorsolateral

223 Furthermore, the SANS data combined with FT-IR spectroscopic analysis of

224 Furthermore, changes in the SANS curves upon DNA binding could be correlated to the

225 f the conformational changes observed in the SANS measurements, and a calorimetric transition enthalp

226 tes a broad transition as is observed in the SANS measurements.

227 no significant differences in change in the SANS total score between glycine and placebo subjects or

228 One site had greater reduction in the SANS total score for patients receiving D-cycloserine re

229 A second site had greater reduction in the SANS total score for placebo patients compared with glyc

230 low solvent ionic strength, analysis of the SANS data shows that the effective PPI for MAb1 is domin

231 etric conformations improving the fit of the SANS data.

232 Results of the SANS measurements are consistent with the light scatteri

233 , 30%, 40%, 50%) were discussed based on the SANS and USANS discovery.

234 Improvement was most notable on the SANS anhedonia and alogia subscales.

235 improvement at the higher DMXB-A dose on the SANS total score and nearly significant improvement on t

236 Shape-reconstruction methods applied to the SANS data indicate that under visible light the protein

237 pe-reconstruction methods are applied to the SANS data to obtain relatively high-resolution conformat

238 random coil shape models were fitted to the SANS measurements at each temperature.

239 toms and functioning were measured using the SANS, SAPS, BPRS, and GSF/GRF.

240 tructures that were most consistent with the SANS data revealed that large movements between the thre

241 significantly inversely correlated with the SANS global ratings of negative symptoms.

242 the NC ligand shell gained directly through SANS and indirectly through SAXS.

243 erve, and if such changes could be linked to SANS.

244 but this observation could not be linked to SANS.

245 but this observation could not be linked to SANS.

246 In response to SANS, 4 B-vitamin supplements were deployed, unpacked on

247 e GLIC was the best-fit crystal structure to SANS curves, with no evidence for divergent mechanisms.

248 The structural details obtained by TR-SANS should help to delineate the key mechanisms that un

249 -resolved small-angle neutron scattering (TR-SANS), we followed the conformational changes that occur

250 We used SANS to determine a structural envelope of SpNOX, the St

251 USH1 proteins including myosin VIIa, USH1G (SANS), CIB2 and harmonin.

252 A first attempt at using SANS to directly characterize the thickness and coverage

253 cessible porosity to N2 was determined using SANS and LPNP data.

254 Contrast variation SANS and SAXS results demonstrate that the peptide inser

255 The primary outcome was SANS or non-SANS diagnosis, determined by OCT-based ODE

256 d studies predominantly exploit 1) SAXS/WAXS/SANS (small- and wide-angle X-ray or neutron scattering)

257 bsequent LDSF missions and vice versa, while SANS ODE severity appeared remarkably similar across LDS

258 Astronauts with SANS had significantly greater median (range) preflight

259 task in noise was negatively correlated with SANS affective flattening score, and hippocampal recruit

260 LDSF were highly likely to be diagnosed with SANS in subsequent LDSF missions and vice versa, while S

261 vide evidence that SEX-LETHAL interacts with SANS-FILLE in the context of the U1 snRNP, through the c

262 ning explicit atomic detergent modeling with SANS measurements has significant potential for structur

263 We observe with SANS that ligands extend up to 15% farther away from the

264 r effects were replicated in a subgroup with SANS-defined prominent negative symptoms (N = 116) and a

265 ht increases in volume vs astronauts without SANS for all 3 venous sinus structures: superior sagitta